Skip to content
Disclosery

Lepercq De Neuflize Asset Management LLC

Follow

13F filer, CIK 1854423, NEW YORK, NY

Lepercq De Neuflize Asset Management LLC reported $103,303,581 across 14 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-13. Its ten largest share positions make up 99.92% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-25-000994

Period
2025-03-31
Reported value
$103M
Holdings
14
Top 10 weight
99.92%
New
2
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ANTXnew+23,234$31.6K
LAVA THERAPEUTICS NVnew+23,000$29.2K
Enzo Biochem Incadded+33,303$12.3K
CLARadded+1,200$4.5K
ESSA PHARMA INCadded+1,500$2.37K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
QQQexited-46,278-$23.7M
ACWIexited-104,300-$12.3M
LFCRreduced-3,000-$21.1K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001420506-25-000994, largest first. % of portfolio is the value over $103,303,581, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SPYSTATE STR SPDR S&P 500 ETF TQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 115,245 shares; 2025Q1: 115,245 shares 115,245$64.5M62.41%0Timeline
EFAISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 466,000 shares; 2025Q1: 466,000 shares 466,000$38.1M36.87%0Timeline
LFCRLIFECORE BIOMEDICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 22,700 shares; 2025Q1: 19,700 shares 19,700$139K0.13%-3,000Timeline
XYLO TECHNOLOGIES LTD - SPO…XYLO TECHNOLOGIES LTD - SPON ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 26,059 shares; 2025Q1: 26,059 shares 26,059$128K0.12%0
WETHWETOUCH TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 67,954 shares; 2025Q1: 67,954 shares 67,954$98.5K0.1%0Timeline
CLARCLARUS CORP NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 21,000 shares; 2025Q1: 22,200 shares 22,200$83.2K0.08%+1,200Timeline
PRESIDIO PPTY TR INCPRESIDIO PPTY TR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 134,125 shares; 2025Q1: 134,125 shares 134,125$77.1K0.07%0
Enzo Biochem IncEnzo Biochem IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 123,000 shares; 2025Q1: 156,303 shares 156,303$57.8K0.06%+33,303
ESSA PHARMA INCESSA PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 30,200 shares; 2025Q1: 31,700 shares 31,700$50.1K0.05%+1,500
ANTXAN2 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 23,234 shares 23,234$31.6K0.03%newTimeline
LAVA THERAPEUTICS NVLAVA THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 23,000 shares 23,000$29.2K0.03%new
BRNBARNWELL INDS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 15,000 shares; 2025Q1: 15,000 shares 15,000$24.3K0.02%0Timeline
DSWLDESWELL INDS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares 10,000$23.6K0.02%0Timeline
LGL GROUP INCLGL GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 26,200 shares; 2025Q1: 26,200 shares 26,200$8.38K0.01%0

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
QQQINVESCO QQQ TR46,278$23.7Mshares
ACWIISHARES TR104,300$12.3Mshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-25-000994 base2025-05-13acceptance time not in the bulk data set